U.S. Pharma Stock News

NYSE:EDU
NYSE:EDUConsumer Services

Assessing New Oriental Education & Technology Group (NYSE:EDU) Valuation After Recent Share Price Weakness

Recent performance snapshot New Oriental Education & Technology Group (NYSE:EDU) has drawn investor attention after a mixed run, with the stock up 2.3% over the past day but down about 11% over the past month. See our latest analysis for New Oriental Education & Technology Group. At a share price of US$46.11, New Oriental’s recent bounce contrasts with a weaker trend, with the 1 month share price return down 11.6% and the year to date share price return down 20.3%, even as the 3 year total...
NYSE:LYV
NYSE:LYVEntertainment

Is It Time To Reassess Live Nation Entertainment (LYV) After Recent Regulatory Scrutiny?

Wondering whether Live Nation Entertainment at around US$167.50 is priced for perfection or still offers room for value is a fair question for any investor looking at the stock today. Recent returns, including 2.0% over the past week, 2.8% over the past month, 15.3% year to date and 16.7% over the last year, along with a 92.4% three year return and 92.0% five year return, show how much sentiment on the stock has shifted over different time frames. Recent news coverage has focused on Live...
NYSE:V
NYSE:VDiversified Financial

Visa Puts AI Agents And Stablecoins To Work In Its Network

Visa (NYSE:V) announced a new partnership with OpenAI to connect its payment network to AI agents, including ChatGPT tools. The company introduced new agentic commerce capabilities that allow AI agents to initiate secure payments on behalf of users. Visa also rolled out additional stablecoin settlement features and new real-world card-to-account B2B payment options through PingPong. Visa, trading at $322.96, is a large global payments company that many investors watch as a barometer for...
NYSE:BFAM
NYSE:BFAMConsumer Services

Bright Horizons (BFAM) Is Up 7.8% After Strong May Retail Sales Lift Consumer-Linked Sentiment

In early June 2026, Bright Horizons Family Solutions benefited from stronger-than-expected May retail sales data, as robust consumer spending lifted sentiment across consumer-related companies, including education and childcare providers. This macro-driven boost highlighted how Bright Horizons, though operating in employer-sponsored childcare and education services, remains sensitive to broader consumer confidence trends that influence discretionary spending and workforce participation...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Trump Media Keeps Truth Social As Merger With TAE Stays On Track

Trump Media & Technology Group (NasdaqGM:DJT) and TAE Technologies have stopped plans to spin off Truth Social and related media assets. The companies reaffirmed their intention to complete their previously announced merger. The change affects how Truth Social and other media properties may be managed and valued within the combined business. Trump Media & Technology Group, the parent of Truth Social, sits at the intersection of social media, politics, and digital content, an area that...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday’s AI Platform Adoption And Integrations Shape Enterprise Valuation Story

Workday (NasdaqGS:WDAY) is seeing rising adoption of its AI powered HR and finance platform across Canada's public sector. The company has been recognized as a winner in the inaugural Josh Bersin Company HR Pacesetter program, highlighting its role in global HR technology. A new integration with AvidXchange introduces Payment Automation capabilities into the Workday ecosystem for enterprise customers. For investors following software as a service platforms, Workday sits at the intersection...
NYSE:ALSN
NYSE:ALSNMachinery

Assessing Allison Transmission (ALSN) Valuation After New French Defense Contract Win

Allison Transmission Holdings (ALSN) has attracted fresh investor attention after winning a contract to supply automatic transmissions for next generation tactical trucks used by the French Land Forces, expanding its role in global defense programs. See our latest analysis for Allison Transmission Holdings. The contract win arrives after a softer patch for the stock, with the 1 month share price return down 8.0% and the 1 week share price return down 4.4%. This is despite the year to date...
NYSE:BALL
NYSE:BALLPackaging

Is It Time To Reconsider Ball (BALL) After Recent Share Price Moves?

Wondering if Ball stock at around US$54.72 is offering good value right now, or if the price already reflects most of the opportunity. Over the last week the stock is up 3.6%, while over the past month it is down 5.2%. Year to date it is up 2.6% and the 1 year return sits at 1.1%. These moves sit against a backdrop of ongoing interest in Ball as a key packaging supplier, including regular coverage of its position in beverage cans and broader materials markets. That context matters because...
NYSE:TREX
NYSE:TREXBuilding

Trex (TREX) Teams With Martha Stewart: Branding Boost Or Test Of Its Innovation Story?

In recent days, Trex Company has been in focus after a broad industrial rebound, easing energy costs for manufacturers, and the previously announced collaboration with lifestyle icon Martha Stewart to promote its composite outdoor living products. This combination of improving sector sentiment and a high-profile branding partnership has sharpened attention on how Trex’s business mix and growth plans could respond to changing demand for sustainable outdoor materials. We’ll now examine how the...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

Why ADMA Biologics (ADMA) Is Up 9.3% After Securities Fraud Class Actions Over ASCENIV Sales Practices

In recent months, multiple law firms have filed securities class action lawsuits against ADMA Biologics alleging channel stuffing, misstated revenues, and undisclosed related‑party distribution arrangements involving its ASCENIV product, covering investors who bought shares between August 2024 and March 2026. These cases, sparked by an investigative short‑seller report, raise questions about ADMA’s revenue quality, internal controls, and transparency around its commercial partnerships. We’ll...
NasdaqGS:OLPX
NasdaqGS:OLPXPersonal Products

Olaplex Holdings (OLPX) Valuation Check After Recent Share Price Momentum Rebuild

Olaplex Holdings stock: event-driven snapshot Olaplex Holdings (OLPX) has drawn fresh attention as investors weigh its current US$2.04 share price, its recent performance over the past 3 months, and an intrinsic discount figure alongside its latest reported financials. See our latest analysis for Olaplex Holdings. While the latest US$2.04 share price has been steady in the very short term, the 90 day share price return of 64.52% alongside a 52.24% one year total shareholder return points to...
NYSE:NUE
NYSE:NUEMetals and Mining

Strong Q1 Results And Steady Dividend Track Might Change The Case For Investing In Nucor (NUE)

In early June 2026, Nucor reported strong first-quarter results with 21% year-over-year sales growth and roughly tripled earnings per share, while its board approved a regular US$0.56 quarterly dividend payable in August, marking the company’s 213th consecutive quarterly payout. Together with very bullish analyst sentiment and expectations for resilient steel demand supported by tariffs, a weaker dollar and reshoring trends, this reinforces Nucor’s position as a key domestic steel producer...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Regulatory Scrutiny Puts Paramount Skydance Merger And Valuation In Focus

Global regulators and politicians are increasing scrutiny of the proposed Paramount Skydance (NasdaqGS:PSKY) and Warner Bros. Discovery mega-merger. The UK competition authority has opened a formal probe focused on competition, content diversity and job impacts. US state and federal officials are weighing in with concerns about antitrust risks, foreign ownership and national security. Regulators are discussing potential remedies that could reshape the eventual structure or scope of any...
NYSE:WM
NYSE:WMCommercial Services

Is Waste Management (WM) Fairly Priced After Recent Share Price Cooldown And DCF Assessment?

If you are wondering whether Waste Management stock is priced fairly or carrying a premium, it helps to start by looking at how its recent returns line up with what you are paying today. The share price last closed at US$224.28, with returns of 2.9% over the past week, 4.7% over the past month, 2.7% year to date, and a decline of 2.7% over the past year, compared with much stronger gains over 3 and 5 years. Recent headlines around Waste Management have focused on its role as a core US waste...
NYSE:VLTO
NYSE:VLTOCommercial Services

Did Veralto’s (VLTO) New US$725 Million Senior Notes Shift Its Capital Allocation Narrative?

On June 1, 2026, Veralto Corporation issued US$725,000,000 of 4.850% senior unsecured notes due January 15, 2032, receiving about US$718.8 million in net proceeds for general corporate purposes. The detailed call and change-of-control provisions, plus the unsecured and unsubordinated status of the notes, offer insight into Veralto’s capital structure priorities and creditor protections. We’ll now examine how this US$725,000,000 senior notes issuance may influence Veralto’s investment...
NasdaqGS:GRAL
NasdaqGS:GRALBiotechs

Does Conflicting NHS-Galleri Data and Lawsuits Change The Bull Case For GRAIL’s Galleri Test (GRAL)?

GRAIL, Inc. has released detailed NHS-Galleri and PATHFINDER 2 data showing that its Galleri multi-cancer early detection test improves stage distribution and screen-detected cancers when added to standard-of-care screening, while maintaining high specificity, strong positive predictive value, and a low rate of invasive follow-up procedures. At the same time, multiple securities class action lawsuits now allege that GRAIL misled investors about NHS-Galleri’s inability to meet its primary...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel Foundry Breakthrough As AI Giants Test Richly Valued Growth Story

Alphabet's Google has ordered more than 3 million tensor processing units from Intel for production in 2028. This is Intel Foundry's largest external manufacturing win so far, focused on advanced AI chips. Nvidia is running early trials on Intel's 18A process and reviewing Intel for future GPU and processor manufacturing. The two deals point to broader industry interest in diversifying chip manufacturing beyond TSMC. Intel, traded as NasdaqGS:INTC, is drawing fresh attention as a potential...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

US Stock Market Today: S&P 500 Futures Fall As Inflation Jitters Grip Tech

The Morning Bull - US Market Morning Update Thursday, Jun, 11 2026 US stock futures are pointing lower this morning, with key contracts for the S&P 500 and Nasdaq 100 both in the red, as investors brace for fresh US inflation data. Headline inflation for May is expected at 4.2% and core at 2.9% year on year, with monthly consumer prices seen rising 0.5%, which would confirm that the cost of living is still rising at an uncomfortable pace. The US 10 year yield is around 4.54%, reflecting...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

A Look At Keurig Dr Pepper (KDP) Valuation After Its Recent Share Price Momentum

Recent performance snapshot Keurig Dr Pepper (KDP) has drawn investor attention after a recent stretch of gains. The stock is up over the past week, month, and past 3 months, alongside solid reported revenue and net income figures. See our latest analysis for Keurig Dr Pepper. At a share price of $31.70, Keurig Dr Pepper’s recent momentum is clear, with a 30 day share price return of 10.41% and a 90 day share price return of 17.71%, even though the 1 year total shareholder return is broadly...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Assessing ON Semiconductor (ON) Valuation After A Powerful Run In Recent Returns

Why ON Semiconductor’s Recent Performance Has Investors Paying Attention ON Semiconductor (ON) has drawn fresh interest after a strong past year for the stock, with total return over the period outpacing its longer term 3 year performance and lifting its market value to about US$45.9b. Over the past year, the stock delivered a total return of about 113%, compared with roughly 18.8% over the past 3 years and around 195% over 5 years, highlighting a particularly strong recent stretch. See our...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle’s Federal HR Cloud Deal Adds New Dimension To AI Story

Oracle (NYSE:ORCL) has secured a major U.S. government contract to provide a cloud-based HR platform for federal agencies. The deal aims to replace existing fragmented HR systems across the federal government with a unified Oracle cloud solution. This contract expands Oracle's federal presence beyond its recent roles in AI infrastructure and policy work. For investors watching NYSE:ORCL, this contract highlights Oracle's cloud applications business in addition to its database and AI...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Assessing Veeva Systems (VEEV) Valuation After Recent Share Price Weakness And Fair Value Gap

Veeva Systems stock snapshot Veeva Systems (VEEV) is back on many investors’ screens after a recent move in the share price, with the stock last closing at US$163.76 and showing mixed returns across different time frames. See our latest analysis for Veeva Systems. The recent pullback, with a 1-day share price return of 2.34% and a year to date share price return down 25.39%, sits alongside a 1-year total shareholder return down 43.25%. This suggests that momentum has been fading despite...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Does Ichor Holdings’ (ICHR) Insider Sale Amid Sector Rally Reveal Anything About Its Risk‑Reward Tradeoff?

In early June 2026, Ichor Holdings’ Chief Financial Officer Greg Swyt sold 6,820 shares, while the company’s stock moved in line with a wider semiconductor equipment sector upswing rather than any firm‑specific catalyst. This combination of insider selling and sector-driven interest highlights how broader industry sentiment, rather than new information about Ichor’s operations, has recently shaped investor attention. We’ll now examine how a sector-wide rally without company-specific...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Kymera Therapeutics (KYMR) Valuation Check As KT-485 Milestone And KT-579 Data Support Long Term Potential

Kymera Therapeutics (KYMR) has been in focus after patient dosing began in the first in human Phase I trial of KT-485 for hidradenitis suppurativa, which triggered a US$20 million milestone payment from Sanofi. See our latest analysis for Kymera Therapeutics. Recent news around KT-485’s first in human trial, fresh KT-579 lupus data, and leadership changes has come alongside mixed short term trading, with a 7 day share price return of 6.86% but a 30 day share price return that is down 6.98%...